128 related articles for article (PubMed ID: 8138715)
1. Simultaneous measurements of chylomicron lipolysis and remnant removal using a doubly labeled artificial lipid emulsion: studies in normolipidemic and hyperlipidemic subjects.
Nakandakare ER; Lottenberg SA; Oliveira HC; Bertolami MC; Vasconcelos KS; Sperotto G; Quintão EC
J Lipid Res; 1994 Jan; 35(1):143-52. PubMed ID: 8138715
[TBL] [Abstract][Full Text] [Related]
2. Metabolism of an artificial emulsion resembling chylomicrons in patients with multiple myeloma.
Hungria VT; Brandizzi LI; Chiattone CS; Bydlowski SP; Maranhão RC
Leuk Res; 1999 Jul; 23(7):637-41. PubMed ID: 10400185
[TBL] [Abstract][Full Text] [Related]
3. Metabolism of chylomicron-like emulsions in carriers of the S447X lipoprotein lipase polymorphism.
Almeida KA; Schreiber R; Amâncio RF; Bydlowski SP; Debes-Bravo A; Issa JS; Strunz CM; Maranhão RC
Clin Chim Acta; 2003 Sep; 335(1-2):157-63. PubMed ID: 12927697
[TBL] [Abstract][Full Text] [Related]
4. Atorvastatin enhances the plasma clearance of chylomicron-like emulsions in subjects with atherogenic dyslipidemia: relevance to the in vivo metabolism of triglyceride-rich lipoproteins.
Sposito AC; Santos RD; Amâncio RF; Ramires JA; Chapman MJ; Maranhão RC
Atherosclerosis; 2003 Feb; 166(2):311-21. PubMed ID: 12535744
[TBL] [Abstract][Full Text] [Related]
5. Effects of hydrochlorothiazide and propranolol treatment on chylomicron metabolism in hypertensive objects.
Bernik MM; Heimann JC; Nakandakare ER; Cazita PM; Nunes VS; Rocha JC; Neves MQ; Quintão EC
Can J Physiol Pharmacol; 2005 Jul; 83(7):617-23. PubMed ID: 16091787
[TBL] [Abstract][Full Text] [Related]
6. Independent regulation of chylomicron lipolysis and particle removal rates: effects of insulin and thyroid hormones on the metabolism of artificial chylomicrons.
Zerbinatti CV; Oliveira HC; Wechesler S; Quintao EC
Metabolism; 1991 Nov; 40(11):1122-7. PubMed ID: 1943739
[TBL] [Abstract][Full Text] [Related]
7. Plasma kinetics of a chylomicron-like emulsion in patients with coronary artery disease.
Maranhão RC; Feres MC; Martins MT; Mesquita CH; Toffoletto O; Vinagre CG; Gianinni SD; Pileggi F
Atherosclerosis; 1996 Sep; 126(1):15-25. PubMed ID: 8879430
[TBL] [Abstract][Full Text] [Related]
8. Chylomicron metabolism in experimental cirrhosis and cholestasis.
Damião AO; Sipahi AM; Albuquerque MR; Laudanna AA; Quintão EC
Res Exp Med (Berl); 1993; 193(2):89-95. PubMed ID: 8516567
[TBL] [Abstract][Full Text] [Related]
9. Apolipoprotein E effectively inhibits lipoprotein lipase-mediated lipolysis of chylomicron-like triglyceride-rich lipid emulsions in vitro and in vivo.
Rensen PC; van Berkel TJ
J Biol Chem; 1996 Jun; 271(25):14791-9. PubMed ID: 8662966
[TBL] [Abstract][Full Text] [Related]
10. Metabolism of chylomicron-like emulsions in patients with Hodgkin's and with non-Hodgkin's lymphoma.
Gonçalves RP; Hungria VT; Chiattone CS; Pozzi DB; Maranhão RC
Leuk Res; 2003 Feb; 27(2):147-53. PubMed ID: 12526920
[TBL] [Abstract][Full Text] [Related]
11. Malignant hypertension is accompanied by marked alterations in chylomicron metabolism.
Bernardes-Silva H; Toffoletto O; Bortolotto LA; Latrilha MC; Krieger EM; Pileggi F; Maranhão RC
Hypertension; 1995 Dec; 26(6 Pt 2):1207-10. PubMed ID: 7498998
[TBL] [Abstract][Full Text] [Related]
12. Lipolysis of emulsion models of triglyceride-rich lipoproteins is altered in male patients with abdominal aorta aneurysm.
Hosni JJ; Vinagre CG; Mady C; Maranhão RC
Braz J Med Biol Res; 2007 Mar; 40(3):305-7. PubMed ID: 17334526
[TBL] [Abstract][Full Text] [Related]
13. Chylomicron metabolism is markedly altered in systemic lupus erythematosus.
Borba EF; Bonfá E; Vinagre CG; Ramires JA; Maranhão RC
Arthritis Rheum; 2000 May; 43(5):1033-40. PubMed ID: 10817556
[TBL] [Abstract][Full Text] [Related]
14. The effects of gemfibrozil upon the metabolism of chylomicron-like emulsions in patients with endogenous hypertriglyceridemia.
Santos RD; Ventura LI; Spósito AC; Schreiber R; Ramires JA; Maranhão RC
Cardiovasc Res; 2001 Feb; 49(2):456-65. PubMed ID: 11164856
[TBL] [Abstract][Full Text] [Related]
15. Defective plasma clearance of chylomicron-like lipid emulsions in Watanabe heritable hyperlipidemic rabbits.
Mamo JC; Bowler A; Elsegood CL; Redgrave TG
Biochim Biophys Acta; 1991 Feb; 1081(3):241-5. PubMed ID: 1998743
[TBL] [Abstract][Full Text] [Related]
16. Metabolism of chylomicrons in patients with congenital lipoatrophic diabetes: a study with emulsion models of chylomicrons.
Wajchenberg BL; Amâncio RF; Santomauro AT; Maranhão RC
Clin Endocrinol (Oxf); 2004 Sep; 61(3):347-52. PubMed ID: 15355451
[TBL] [Abstract][Full Text] [Related]
17. Chylomicron-remnant clearance in homozygote and heterozygote Watanabe-heritable-hyperlipidaemic rabbits is defective. Lack of evidence for an independent chylomicron-remnant receptor.
Bowler A; Redgrave TG; Mamo JC
Biochem J; 1991 Jun; 276 ( Pt 2)(Pt 2):381-6. PubMed ID: 2049068
[TBL] [Abstract][Full Text] [Related]
18. Effects of etofibrate upon the metabolism of chylomicron-like emulsions in patients with coronary artery disease.
Spósito AC; Maranhão RC; Vinagre CG; Santos RD; Ramires JA
Atherosclerosis; 2001 Feb; 154(2):455-61. PubMed ID: 11166779
[TBL] [Abstract][Full Text] [Related]
19. Features of cholesterol structure that regulate the clearance of chylomicron-like lipid emulsions.
Mortimer BC; Tso P; Phan CT; Beveridge DJ; Wen J; Redgrave TG
J Lipid Res; 1995 Sep; 36(9):2038-53. PubMed ID: 8558091
[TBL] [Abstract][Full Text] [Related]
20. Chylomicron metabolism in patients submitted to cardiac transplantation.
Vinagre CG; Stolf NA; Bocchi E; Maranhão RC
Transplantation; 2000 Feb; 69(4):532-7. PubMed ID: 10708107
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
